NCT00408915View on ClinicalTrials.gov

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 31, 2006

Conditions

Parkinson's Disease

Interventions

DRUG

Continuous Subcutaneous Lisuride Infusion

Trial Locations (1)

Unknown

Imerem GmbH, Nuremberg

Sponsors

Lead Sponsor

Axxonis Pharma AG

All Listed Sponsors

lead

Axxonis Pharma AG

INDUSTRY

NCT00408915 - Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion | Biotech Hunter | Biotech Hunter